Sep
9
Mon
2019
Thriving Through Change: The Enduring Benefits of Resiliency Through Mindfulness
Sep 9 @ 11:00 am – 12:00 pm

Top research institutions have substantiated the powerful benefits of mindfulness practices on increased productivity, critical decision-making, and out-of-the-box problem-solving. In this workshop, you will receive content about how and why we can react negatively to stress and the latest research in neuroscience on the most effective techniques that take us from overwhelmed, anxious, and uncertain to clear, calm, and resilient. Learn how mindfulness, and resilience, coupled with compassion, can markedly improve your daily experience. In this workshop, you will explore and practice 3 takeaways that will change your relationship to stress now and pre-wire your brain for resiliency in the future.

Instructor: Patty McLucas is the founder of Mindful Wellness and has more than 20 years of experience as a wellness consultant. She teaches classes in mindfulness for Stanford’s Cancer Supportive Care Program and Health Improvement Program as well as other organizations including Apple and Google.

Please RSVP at this link:
https://stanforduniversity.qualtrics.com/jfe/form/SV_b1uwefC68ryApEx

Sep
12
Thu
2019
Laura Jones: The Poisoning of Jane Stanford
Sep 12 @ 11:30 am – 1:00 pm

Speaker: Laura Jones is the Director of Heritage Services and Special Projects. She is also the  University Archaeologist and an Amy J. Blue award winner.

Oct
11
Fri
2019
2019 Fogarty Lecture
Oct 11 @ 4:00 pm – 5:00 pm

21st Annual Thomas J. Fogarty Lecture: Focus on Innovation featuring Brook Byers, Founding Partner, Kleiner Perkins

The Fogarty lectureship was established to bring together a diverse community in Silicon Valley focusing on leaders in discovery, invention, innovation, and entrepreneurship. This event is sponsored by the Stanford Byers Center for Biodesign, Fogarty Institute for Innovation and the Stanford Department of Surgery.

About Brook Byers:
Brook Byers is a founding member of Kleiner Perkins. A venture capital investor since 1972, Brook has been closely involved with more than 60 new technology-based ventures, many of which have become public companies. He formed the first life sciences practice group in the venture capital profession in 1984 and led KP to become a premier venture capital firm in the medical, healthcare and biotechnology sectors. KP has invested in and helped build more than 120 life sciences companies that have developed hundreds of products to treat underserved medical needs for many millions of patients. Brook has been an innovator in precision medicine and health genomics, antibodies and devices. He was the founding president and then chairman of four biotechnology companies that were incubated in KP’s offices and went on to become public companies with an aggregate market value of more than US $8 billion. He serves on the board of directors of Epiodyne, Enjoy, Newsela, Octave and Verana Health.

Brook serves on the Board of Overseers of the University of California San Francisco medical campus and hospitals, the Stanford Medicine Advisory Council, the Board of Directors of the New Schools Foundation, the Advisory Board of Stanford’s Center for Precision Health and Integrated Diagnostics and the Stanford Center for Biodesign. In 2007, UCSF awarded Brook the UCSF Medal, its honorary degree equivalent. In 2008, Brook was elected a fellow of the American Academy of Arts and Sciences. In 2009, he received the Lifetime Achievement Award from the National Venture Capital Association. In 2010, he received an honorary Ph.D. from Georgia Institute of Technology.

Raised in Atlanta, Georgia, Brook graduated with a bachelor’s degree in electrical engineering from Georgia Tech and received an M.B.A. from Stanford University.

Register: http://bit.ly/FogartyLecture-2019

Jul
27
Mon
2020
Residency Informational Webinar
Jul 27 @ 5:00 pm – 6:00 pm

Join us Monday, July 27 at 5PM PST (8PM EST) to learn about the Department of Surgery at Stanford University and our residency programs. This one-hour program offers attendees the opportunity to hear from our Department Chair, Vice Chair of Education, and Residency Program Directors. Register here!

Sep
15
Tue
2020
Wellness Lecture: Carter Lebares, MD
Sep 15 @ 7:00 am – 8:00 am
Oct
20
Tue
2020
Grand Rounds: Dr. James Wall
Oct 20 @ 7:00 am – 8:00 am
Oct
30
Fri
2020
22nd Annual Fogarty Lecture
Oct 30 @ 4:00 pm – 5:00 pm

The 22nd Annual Thomas J. Fogarty, MD Lecture: Focus on Innovation

Friday, October 30, 2020 | 4pm
LKSC – Berg Hall | Stanford University

Featuring Julio C. Palmaz, MD, radiologist, honorary Ashbel Smith Professor at the University of Texas Health Science Center, inventor, entrepreneur, and vintner.
The Fogarty lectureship was established to bring together a diverse community in Silicon Valley focusing on leaders in discovery, invention, innovation, and entrepreneurship. This event is sponsored by Stanford Byers Center for Biodesign, Fogarty Institute for Innovation and Stanford Department of Surgery. Watch this space for more information.

Register here.

Mar
30
Tue
2021
Grand Rounds: Drs. Matias Bruzoni & Janey Pratt
Mar 30 @ 7:00 am – 8:00 am
Mar
22
Tue
2022
Chandler Lecture
Mar 22 @ 7:00 am – 8:00 am
Sep
30
Fri
2022
24th Annual Fogarty Lecture
Sep 30 @ 4:00 pm – 5:00 pm

Mir Imran has accepted the invitation to be the 24th annual Fogarty guest lecturer.  The date of the event is Friday September 30, 2022 at 4pm.  It will be a hybrid event.

Mir Imran, Chairman & CEO of InCube Labs, is a prolific healthcare innovator and entrepreneur, who has been developing and commercializing breakthrough medical innovations for over 40 years.

Mir began his career as a healthcare entrepreneur in the late 1970’s with his pioneering contributions to the first FDA-approved Implantable Defibrillator (ICD). Since then, Mir has founded more than 20 life sciences companies and two tech companies, 15 of which have seen liquidity events (IPO/Acquisition). His most recent exit, Rani Therapeutics Holdings Inc., went public on Nasdaq in July 2021.

Mir’s inventions have saved the lives of millions of patients, and many have become the standards of care. He has developed innovative therapies for a number of chronic diseases, including, anemia, chronic pain, stroke, diabetes, and several cardiovascular conditions. His recent company, Rani Therapeutics, is revolutionizing the management of chronic diseases, by replacing painful injectable therapies with oral biologics.

Mir holds more than 800 issued & pending US patents. In 2016, QMed named Mir as one of the “Top 50 Medical Inventors of All Time”. Mir is a fellow of the National Academy of Engineering, the National Academy of Inventors and the American Institute of Medical & Biological Engineers. In 2009, Mir was inducted into the Rutgers University Hall of Distinguished Alumni.

Mir is also the co-founder & managing director of InCube Ventures, LP, a medtech/biotech venture capital fund. In addition, Mir serves on the boards of several life science companies, on the advisory board of the Lemelson Foundation, and is a trustee of the UCSC Foundation. He is also an Adjunct Professor of Bioengineering at the University of Pittsburgh and actively supports the promotion and teaching of innovation and entrepreneurship at colleges and universities. As a philanthropist, Mir is passionately supporting education in India and US, especially for underprivileged students.